Highlights the challenge of identifying G6PD deficiency in infants.
Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones!
Raises thresholds for phototherapy and exchange transfusion.
Includes gestational age and risk factors for neurotoxicity in the thresholds.
Adds when to check for rebound after stopping phototherapy.
Offers how to provide intensive phototherapy and when home phototherapy is an option.
Introduces “escalation of care” for serum bilirubin close to exchange transfusion level.
About Neurotoxicity Risk Factors (updated May 2024)
Selection of one or more of these risk factors (optional), including an elevated ETCOc (end-tidal carbon monoxide, corrected to ambient CO), will give guideline recommendations for the presence of neurotoxicity risk factors.
Gestational age (required) automatically provides the appropriate recommendation from the AAP guideline.